Modified Nucleotides For Polynucleotide Sequencing

Patent No. EP3002289 (titled "Modified Nucleotides For Polynucleotide Sequencing") was filed by Illumina Cambridge on Aug 22, 2003. The application was issued on Feb 28, 2018.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
MGI TECH HONG KONGApr 29, 2020BUDDE SCHOU
HOFFMANN EITLENov 28, 2018HOFFMANN EITLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3002289

ILLUMINA CAMBRIDGE
Application Number
EP15184520A
Filing Date
Aug 22, 2003
Status
Revoked
Jun 19, 2023
Publication Date
Feb 28, 2018